Get the Stockscreener App
13.52
0.60%
0.08
Pre-market:
13.22
-0.30
-2.22%
Clearpoint Neuro Inc stock is traded at $13.52, with a volume of 324.82K.
It is up +0.60% in the last 24 hours and up +16.15% over the past month.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
See More
Previous Close:
$13.44
Open:
$13.755
24h Volume:
324.82K
Relative Volume:
0.56
Market Cap:
$405.46M
Revenue:
$40.61M
Net Income/Loss:
$-29.07M
P/E Ratio:
-13.41
EPS:
-1.0081
Net Cash Flow:
$-26.70M
1W Performance:
+1.05%
1M Performance:
+16.15%
6M Performance:
+9.21%
1Y Performance:
+17.16%
1-Day Range:
$13.25
$14.04
1-Week Range:
$12.82
$14.20
52-Week Range:
$8.27
$30.10
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Name
Clearpoint Neuro Inc
Sector
Industry
Phone
(949) 900-6833
Address
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Compare CLPT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
13.52 | 405.46M | 40.61M | -29.07M | -26.70M | -1.0081 |
ABT
Abbott Laboratories
|
88.67 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.94 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
80.38 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
46.76 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.28 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-25-24 | Resumed | B. Riley Securities | Buy |
| Oct-24-23 | Initiated | Stifel | Buy |
| Feb-16-23 | Resumed | B. Riley Securities | Buy |
| Apr-05-22 | Resumed | B. Riley Securities | Buy |
| Mar-18-21 | Initiated | Lake Street | Buy |
| Jul-17-20 | Initiated | B. Riley FBR | Buy |
View All
Clearpoint Neuro Inc Stock (CLPT) Latest News
ClearPoint Neuro Q1 2026 Earnings: EPS Misses Estimates Amid Operational ChallengesShort-Term Outlook - newsline.com
Stifel reiterates Clearpoint Neuro stock rating on neurosurgery platform - Investing.com
Stifel reiterates Clearpoint Neuro stock rating on neurosurgery platform By Investing.com - Investing.com Canada
ClearPoint Neuro (CLPT) director exercises options and withholds shares for taxes - Stock Titan
Why (CLPT) Price Action Is Critical for Tactical Trading - Stock Traders Daily
ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint - ACCESS Newswire
Director at ClearPoint Neuro (NASDAQ: CLPT) sells shares to cover taxes - Stock Titan
CLPT: Director compensation shares (5,145) to be sold via Form 144 (06/01/2026) - Stock Titan
[144] ClearPoint Neuro, Inc. SEC Filing - Stock Titan
ClearPoint Neuro, Inc.: ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint - FinanzNachrichten.de
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Director Of ClearPoint Neuro Sold 25% Of Their Shares - simplywall.st
ClearPoint Neuro plans entry into focused ultrasound market By Investing.com - Investing.com India
ClearPoint Neuro plans entry into focused ultrasound market - Investing.com UK
Understanding Momentum Shifts in (CLPT) - Stock Traders Daily
Brain ultrasound deal tests drug delivery across blood-brain barrier - Stock Titan
How The ClearPoint Neuro (CLPT) Narrative Is Shifting On Partnerships Valuation And FDA Risks - Yahoo Finance
ClearPoint Neuro (CLPT) director receives grant of 12,820 RSUs - Stock Titan
ClearPoint Neuro (CLPT) director receives 12,820 restricted stock units in equity grant - Stock Titan
[Form 4] ClearPoint Neuro, Inc. Insider Trading Activity - Stock Titan
Director at ClearPoint Neuro (CLPT) receives 12,820 restricted stock units - Stock Titan
Director at ClearPoint Neuro (NASDAQ: CLPT) awarded 12,820 RSUs - Stock Titan
Director at ClearPoint Neuro (CLPT) receives 12,820 restricted stock units grant - Stock Titan
CLPT Q1 2026 Earnings: EPS Misses Estimates as Revenue Details Remain UndisclosedAnnual Financial Report - newsline.com
ClearPoint Neuro Shareholders Approve Incentive Plan and Directors - The Globe and Mail
ClearPoint Neuro Q1 2026 Earnings: EPS Misses Estimates Despite Positive Stock MovementPre-Earnings Setup - newsline.com
Director Matthew Klein of ClearPoint Neuro (CLPT) receives 12,417 shares from RSU vesting - Stock Titan
Tax sale by ClearPoint (CLPT) director after RSU vesting - Stock Titan
Director at ClearPoint Neuro (NASDAQ: CLPT) gains 12,417 shares via RSU vesting - Stock Titan
ClearPoint Neuro (CLPT) investors approve directors, pay and updated incentive plan - Stock Titan
ClearPoint Neuro (CLPT) director converts 12,417 RSUs into common shares - Stock Titan
ClearPoint Neuro (CLPT) director settles 12,417 RSUs into common stock - Stock Titan
Director Pascal Girin converts 12,417 RSUs into ClearPoint Neuro (CLPT) common shares - Stock Titan
ClearPoint Neuro (CLPT) director converts 12,417 RSUs into common stock holdings - Stock Titan
16,000-share sale by CLPT (NASDAQ: CLPT) from vested restricted plan - Stock Titan
ClearPoint Neuro Earnings Call Signals Growth With Strain - TipRanks
Compared to estimates, ClearPoint Neuro (CLPT) Q1 earnings: A look at key metrics - MSN
ClearPoint Neuro Inc (CLPT) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic Growth By GuruFocus - Investing.com Canada
Clearpoint Neuro, Valneva, Rocket Lab and other big stocks moving lower in Wednesday's pre-market session - MSN
Avoiding Lag: Real-Time Signals in (CLPT) Movement - Stock Traders Daily
ClearPoint Neuro stock (US18507C1099): MAK Capital discloses 6.3% passive stake in CLPT - AD HOC NEWS
ClearPoint Neuro2026 Funding Rounds & List of Investors - Tracxn
MAK Capital reports 6.3% stake in ClearPoint Neuro (CLPT) via Schedule 13G/A - Stock Titan
ClearPoint Neuro Announces CE Marking of Velocity Alpha MR High Speed Surgical Drill System, Further Expanding Drug Delivery Ecosystem and Global Footprint - ACCESS Newswire
Stifel reiterates Clearpoint Neuro stock Buy rating after Q1 beat - Investing.com UK
Stifel Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Maintains Target Price $16 - Moomoo
Stifel reiterates Clearpoint Neuro stock Buy rating after Q1 beat By Investing.com - Investing.com Nigeria
Clearpoint Neuro Inc Stock (CLPT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):